| Home | E-Submission | Sitemap | Editorial Office |  
top_img
    
SPECIAL ARTICLE 2020 June 2
Choosing Wisely: The Korean Perspective and Launch of the ‘Right Decision in Cancer Care’ Initiative
Government healthcare expenditure is rising in Korea, and the costs incurred by patients in Korea exceed those incurred by patients in other Organization for Economic Co-operation and Development countries. Despite the increasing health expenditure, patient demand for services i...
ORIGINAL ARTICLE 2020 January 10
PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
Purpose We provide a comparison between 22C3 pharmDx and SP263 assay, for evaluating programmed death ligand 1 (PD-L1) expression in advanced gastric cancer (GC) patients. Materials and Methods The PD-L1 immunohistochemistry by 22C3 pharmDx and SP263 assays was performed in...
ORIGINAL ARTICLE 2020 January 28
Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study
Purpose This retrospective study aimed to evaluate the distribution pattern and prognostic value of 21-gene recurrence score (RS) in Chinese patients with mucinous breast cancer (MC) and compared with infiltrating ductal carcinoma (IDC). Materials and Methods Patients diagnos...
ORIGINAL ARTICLE 2020 January 28
Clinicopathological Features of Patients with the BRCA1 c.5339T>C (p.Leu1780Pro) Variant
Purpose Recent studies revealed the BRCA1 c.5339T>C, p.Leu1780Pro variant (L1780P) is highly suggested as a likely pathogenic. The aim of this study was to evaluate clinicopathologic features of L1780P with breast cancer (BC) using multicenter data from Korea to reinforce the e...
Current Issue
Volume 52(3); Jul 2020
Volume 52(2); April 2020
Volume 52(1); January 2020
RSS feed


(2016~2020)

  • Most-cited are based on citations from 2018 ~ 2020.
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2018;50(2):303-316.   Published online March 21, 2018    DOI: https://doi.org/10.4143/crt.2018.143
                                     Cited By 194
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2019;51(2):417-430.   Published online March 18, 2019    DOI: https://doi.org/10.4143/crt.2019.138
                                     Cited By 77
    The Generation and Application of Patient-Derived Xenograft Model for Cancer Research
    Jaeyun Jung, Hyang Sook Seol, Suhwan Chang
    Cancer Res Treat. 2018;50(1):1-10.   Published online September 13, 2017    DOI: https://doi.org/10.4143/crt.2017.307
                                     Cited By 53
    Ferroptosis: A Novel Anti-tumor Action for Cisplatin
    Jipeng Guo, Bingfei Xu, Qi Han, Hongxia Zhou, Yun Xia, Chongwen Gong, Xiaofang Dai, Zhenyu Li, Gang Wu
    Cancer Res Treat. 2018;50(2):445-460.   Published online May 10, 2017    DOI: https://doi.org/10.4143/crt.2016.572
                                     Cited By 32
    Prediction of Cancer Incidence and Mortality in Korea, 2018
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
    Cancer Res Treat. 2018;50(2):317-323.   Published online March 21, 2018    DOI: https://doi.org/10.4143/crt.2018.142
                                     Cited By 31
    Circular RNA-ZFR Inhibited Cell Proliferation and Promoted Apoptosis in Gastric Cancer by Sponging miR-130a/miR-107 and Modulating PTEN
    Tonglei Liu, Shuang Liu, Yu Xu, Ruo Shu, Feng Wang, Cheng Chen, Yujian Zeng, Huayou Luo
    Cancer Res Treat. 2018;50(4):1396-1417.   Published online January 24, 2018    DOI: https://doi.org/10.4143/crt.2017.537
                                     Cited By 30
    Prediction of Cancer Incidence and Mortality in Korea, 2019
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
    Cancer Res Treat. 2019;51(2):431-437.   Published online March 18, 2019    DOI: https://doi.org/10.4143/crt.2019.139
                                     Cited By 27
    Light Alcohol Drinking and Risk of Cancer: A Meta-Analysis of Cohort Studies
    Yoon-Jung Choi, Seung-Kwon Myung, Ji-Ho Lee
    Cancer Res Treat. 2018;50(2):474-487.   Published online May 22, 2017    DOI: https://doi.org/10.4143/crt.2017.094
                                  Supplementary         Cited By 21
    Long Noncoding RNA HEIH Promotes Colorectal Cancer Tumorigenesis via Counteracting miR-939‒Mediated Transcriptional Repression of Bcl-xL
    Chunhui Cui, Duanyang Zhai, Lianxu Cai, Qiaobin Duan, Lang Xie, Jinlong Yu
    Cancer Res Treat. 2018;50(3):992-1008.   Published online October 30, 2017    DOI: https://doi.org/10.4143/crt.2017.226
                                     Cited By 21
    Nationwide Trends in the Incidence of Melanoma and Non-melanoma Skin Cancers from 1999 to 2014 in South Korea
    Chang-Mo Oh, Hyunsoon Cho, Young-Joo Won, Hyun-Joo Kong, Yun Ho Roh, Ki-Heon Jeong, Kyu-Won Jung
    Cancer Res Treat. 2018;50(3):729-737.   Published online July 14, 2017    DOI: https://doi.org/10.4143/crt.2017.166
                                  Supplementary         Cited By 19
    Trends in Gastric Cancer Incidence According to the Clinicopathological Characteristics in Korea, 1999-2014
    Bang Wool Eom, Kyu-Won Jung, Young-Joo Won, Hannah Yang, Young-Woo Kim
    Cancer Res Treat. 2018;50(4):1343-1350.   Published online January 15, 2018    DOI: https://doi.org/10.4143/crt.2017.464
                                  Supplementary         Cited By 19
    Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
    Tae Min Kim, Keun-Wook Lee, Do-Youn Oh, Jong-Seok Lee, Seock-Ah Im, Dong-Wan Kim, Sae-Won Han, Yu Jung Kim, Tae-You Kim, Jee Hyun Kim, Hyesun Han, Woo Ho Kim, Yung-Jue Bang
    Cancer Res Treat. 2018;50(3):835-842.   Published online August 29, 2017    DOI: https://doi.org/10.4143/crt.2017.303
                                  Supplementary         Cited By 16
    Comparative Effectiveness of Abdominal versus Laparoscopic Radical Hysterectomy for Cervical Cancer in the Postdissemination Era
    Jin Hee Kim, Kyungjoo Kim, Seo Jin Park, Jung-Yun Lee, Kidong Kim, Myong Cheol Lim, Jae Weon Kim
    Cancer Res Treat. 2019;51(2):788-796.   Published online September 11, 2018    DOI: https://doi.org/10.4143/crt.2018.120
                                  Supplementary         Cited By 16
    The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients
    Li-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Ming-Yuan Chen, Chong Zhao, Xiang Guo, Chao-Nan Qian, Mu-Sheng Zeng, Jin-Xin Bei, Jing Tan, Shuai Chen, Ming-Huang Hong, Jian-Yong Shao, Ying Sun, Jun Ma, Hai-Qiang Mai
    Cancer Res Treat. 2018;50(1):19-29.   Published online April 5, 2017    DOI: https://doi.org/10.4143/crt.2016.595
                                  Supplementary         Cited By 15
    Effectiveness of Gastric Cancer Screening on Gastric Cancer Incidence and Mortality in a Community-Based Prospective Cohort
    Heewon Kim, Yunji Hwang, Hokyung Sung, Jieun Jang, Choonghyun Ahn, Sang Gyun Kim, Keun-Young Yoo, Sue K. Park
    Cancer Res Treat. 2018;50(2):582-589.   Published online June 9, 2017    DOI: https://doi.org/10.4143/crt.2017.048
                                  Supplementary         Cited By 15
    Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
    Seho Park, Ja Seung Koo, Gun Min Kim, Joohyuk Sohn, Seung Il Kim, Young Up Cho, Byeong-Woo Park, Vivian Youngjean Park, Jung Hyun Yoon, Hee Jung Moon, Min Jung Kim, Eun-Kyung Kim
    Cancer Res Treat. 2018;50(3):801-812.   Published online August 17, 2017    DOI: https://doi.org/10.4143/crt.2017.210
                                     Cited By 14
    Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study
    Loredana Amoroso, Giovanni Erminio, Guy Makin, Andrew D. J. Pearson, Penelope Brock, Dominique Valteau-Couanet, Victoria Castel, Marlène Pasquet, Genevieve Laureys, Caroline Thomas, Roberto Luksch, Ruth Ladenstein, Riccardo Haupt, Alberto Garaventa, SIOPEN Group
    Cancer Res Treat. 2018;50(1):148-155.   Published online March 21, 2017    DOI: https://doi.org/10.4143/crt.2016.511
                                     Cited By 13
    FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation
    Jinju Park, Yiseul Choi, Young San Ko, Younghoon Kim, Jung-Soo Pyo, Bo Gun Jang, Min A Kim, Jae-Seon Lee, Mee Soo Chang, Jong-Wan Park, Byung Lan Lee
    Cancer Res Treat. 2018;50(1):239-254.   Published online March 24, 2017    DOI: https://doi.org/10.4143/crt.2016.580
                                     Cited By 13
    Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study
    Ki Sun Jung, Su Jin Lee, Se Hoon Park, Jae-Lyun Lee, Se-Hoon Lee, Jae Yun Lim, Jung Hun Kang, Suee Lee, Sun Young Rha, Kyung Hee Lee, Ho Young Kim, Ho Yeong Lim
    Cancer Res Treat. 2018;50(2):488-494.   Published online May 22, 2017    DOI: https://doi.org/10.4143/crt.2016.584
                                  Supplementary         Cited By 13
    Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer
    Makoto Nishio, Dong-Wan Kim, Yi-Long Wu, Kazuhiko Nakagawa, Benjamin J. Solomon, Alice T. Shaw, Satoshi Hashigaki, Emiko Ohki, Tiziana Usari, Jolanda Paolini, Anna Polli, Keith D. Wilner, Tony Mok
    Cancer Res Treat. 2018;50(3):691-700.   Published online July 6, 2017    DOI: https://doi.org/10.4143/crt.2017.280
                                  Supplementary         Cited By 13
    Korean Cancer Association
    E-Submission
    EndNote Output Style
    Email Alert
    Impact factor
    SCImago Journal & Country Rank
    PubMed Central
    MEDLINE/PubMed
    Scopus
    KoreaMed
    KoMCI
    ScienceCentral
    GoogleScholar
    Similarity Check
    Crossref Cited-by Linking
    CrossMark
    Funder Registry
    ORCID
    COPE
    Editorial Office
    Korean Cancer Association
    Room 1824, Gwanghwamun Officia
    92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
    TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community